Search results
Between 30% and 50% of cancer deaths could be prevented by modifying or avoiding key risk factors and implementing existing evidence-based prevention strategies. The cancer burden can also be reduced through early detection of cancer and management of patients who develop cancer.
- Cancer
Improved access to oral morphine is strongly recommended for...
- Cancer
1 sty 2019 · The World Health Organization (WHO) has developed Guidelines for the pharmacologic and radiotherapeutic management of cancer pain in adults and adolescents to provide evidence-based guidance to initiating and managing cancer pain.
Despite published guidelines and educational programs on the assessment and treatment of cancer-related pain, in any stage of oncological disease, unrelieved pain continues to be a substantial worldwide public health concern in patients with either solid or hematological malignancies.
Cancer-related pain is a significant problem that can be well managed when evidence-based strategies are implemented. Evidence-based interventions for cancer pain management fall into four categories: acute, chronic, refractory, and breakthrough. Clinicians should use this supplement as a reference to manage pain in daily practice.
3 lut 2022 · Improved access to oral morphine is strongly recommended for the treatment of moderate to severe cancer pain, suffered by over 80% of people with cancer in the terminal phase. WHO response
The following agents are not recommended for patients with cancer: (1) mixed agonist-antagonists (eg, butorphanol, pentazocine); (2) meperidine; and (3) placebos. Mixed agonist-antagonists should not be used in combination with opioid agonist drugs for cancer pain management.
1 maj 2017 · Morphine and other strong opioids are key to managing pain in advanced cancer.
